Nexium I.V. (Esomeprazole)

Esomeprazole, the active ingredient in Nexium I.V., is a proton pump inhibitor presented as an intravenous solution for intravenous use. It reduces gastric acid secretion and is employed in the management of acid‑related disorders such as gastro‑esophageal reflux disease, erosive esophagitis, peptic ulcer disease, and for stress‑ulcer prophylaxis in hospitalized patients.

GNH USA supplies Nexium I.V. as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company provides regulatory‑approved batches, ensuring quality and consistency for clinical use across global healthcare facilities.

Nexium I.V. (esomeprazole) is indicated for several acid‑related gastrointestinal conditions.

- Gastro‑esophageal reflux disease (GERD): reduces acid exposure and promotes healing of esophageal mucosa. - Erosive esophagitis: facilitates ulcer healing and symptom relief. - Peptic ulcer disease: supports ulcer resolution by suppressing gastric acid. - Stress ulcer prophylaxis: prevents development of stress‑related gastric lesions in critically ill patients.

Common and serious adverse reactions have been reported with intravenous esomeprazole.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: loose stools. - Nausea: occasional. - Abdominal pain: discomfort in the stomach area.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis. - Anaphylaxis: life‑threatening allergic reaction. - Stevens‑Johnson syndrome: severe skin reaction.

When using Nexium I.V., clinicians should consider several precautionary measures to ensure patient safety.

- Renal impairment: monitor renal function and adjust therapy if needed. - Hepatic impairment: use with caution; assess liver enzymes. - Elderly patients: increased risk of electrolyte disturbances; observe closely. - Concomitant clopidogrel: may reduce antiplatelet effect; evaluate bleeding risk. - Pregnancy: safety not established; weigh benefits against potential risks. - Store at ambient temperature: keep in original container, protect from light and moisture.

Esomeprazole may interact with several medicines, affecting their efficacy or safety.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet activity. - Warfarin: increased INR and bleeding risk. - Methotrexate: heightened toxicity due to reduced renal clearance.

Moderate Interactions (Monitor Closely): - Digoxin: increased serum concentrations. - Atazanavir: decreased absorption of the antiviral. - Ketoconazole: reduced antifungal exposure.